Evolving cardiac biomarkers for immune checkpoint inhibitor related myocarditis in cancer patients

Affiliations

• ¹ Norfolk and Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
• ² Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.
• ³ Barts Cancer Centre, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
• ⁴ Cardio-Oncology Service, Barts Heart Centre, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
• ⁵ Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, London, UK.
• ⁶ Medical Oncology, Medway NHS Foundation Trust, Gillingham, Kent, UK.
• ⁷ Immuno-Oncology Clinical Network, UK.
• ⁸ London Northwest University Healthcare NHS Trust, London, UK.
• ⁹ National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.
• ¹⁰ Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK.
• ¹¹ Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
• ¹² Cardio-Oncology Service, Royal Brompton Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
• ¹³ The Royal Marsden Hospital, The Royal Marsden NHS Foundation Trust, London, UK.
• ¹⁴ Cardio-Oncology Service, University College London Hospitals NHS Foundation Trust, London, UK.
• ¹⁵ Hatter Cardiovascular Institute, UCL Institute of Cardiovascular Science, University College London, London, UK.